Pseudorabies virus (PRV) is protected from complement attack by cellular factors and glycoprotein C (gC)

Virus Research

Volumn 84, Issue 1-2, 2002, Pages 79-87

  Maeda, Kohshi ^a   Hayashi, Sunao ^a   Tanioka, Yoshikuni ^b   Matsumoto, Yasunobu ^a   Otsuka, Haruki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

Author keywords

Complement; GC; Homologous restriction; PRV

Indexed keywords

COMPLEMENT; PROTEIN C;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DELETION MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSEUDORABIES HERPETOVIRUS; RABBIT; SWINE; VIRION; VIRUS NEUTRALIZATION; VIRUS RESISTANCE;

ANIMALS; CELL LINE; COMPLEMENT SYSTEM PROTEINS; GLYCOPROTEINS; HERPESVIRUS 1, SUID; RABBITS; SPECIES SPECIFICITY; SWINE; VIRAL PROTEINS; VIRION;

ORYCTOLAGUS CUNICULUS; SUID HERPESVIRUS 1; SUS SCROFA;

EID: 0037139475     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(01)00417-8     Document Type: Article

References (36)

1. Complement-inhibiting activities of human CD59 and analogues from rat, sheep, and pig are not homologously restricted
2. Brefeldin A arrests the maturation and egress of herpes simplex virus particles during infection
3. CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells
4. Complement component C3b binds directly to purified glycoprotein C of herpes simplex virus types 1 and 2
5. Live-cell analysis of a green fluorescent protein-tagged herpes simplex virus infection
6. Viral activation of the coagulation cascade: Molecular interactions at the surface of infected endothelial cells
7. Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells
8. Binding of complement component C3b to glycoprotein gC of herpes simplex virus type 1: Mapping of gC-binding sites and demonstration of conserved C3b binding in low-passage clinical isolates
9. The phospholipid composition of extracellular herpes simplex virions differs from that of host cell nuclei
10. Egress of alphaherpesviruses: Comparative ultrastructural study
11. Homologous species restriction in lysis of erythrocytes by terminal complement proteins
12. Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities
13. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity
14. Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria
15. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway
16. The structural basis for complement receptor type 2 (CR2, CD21)-mediated alternative pathway activation of complement: Studies with CR2 deletion mutants and vaccinia virus complement-control protein-CR2 chimeras
17. Binding of properdin to solid-phase immune complexes: Critical role of the classical activation pathway of complement
18. Control of Aujeszky's disease
19. Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes
20. Viral interference with antibody and complement
21. Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement
22. Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity
23. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers
24. The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factor
25. Regulation of complement
26. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection
27. The human complement regulatory protein CD59 binds to the a-chain of C8 and to the "b" domain of C9
28. A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement
29. The requirement of localized, CR2-mediated, alternative pathway activation of complement for covalent deposition of C3 fragments on normal B cells
30. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9
31. Binding of complement component C3b to glycoprotein C is modulated by sialic acid on herpes simplex virus type 1-infected cells
32. Isolation from human erythrocytes of a new membrane protein which inhibits the formation of complement transmembrane channels
33. Herpes simplex virus type 1-induced hemagglutination: Glycoprotein C mediates virus binding to erythrocyte surface heparan sulfate
34. Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope
35. Replacement of the pseudorabies virus glycoprotein gIII gene with its postulated homolog, the glycoprotein gC gene of herpes simplex virus type 1
36. Lytic activity of C5-9 complexes for erythrocytes from the species other than sheep: C9 rather than C8-dependent variation in lytic activity